<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ssmu</journal-id><journal-title-group><journal-title xml:lang="ru">Бюллетень сибирской медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Bulletin of Siberian Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-0363</issn><issn pub-type="epub">1819-3684</issn><publisher><publisher-name>Siberian State Medical University, the Ministry of Healthcare of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20538/1682-0363-2022-1-28-34</article-id><article-id custom-type="elpub" pub-id-type="custom">ssmu-4691</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL PAPERS</subject></subj-group></article-categories><title-group><article-title>Изучение противовоспалительной и иммунотропной активности секретома мультипотентных мезенхимальных стромальных клеток, индуцированных эритропоэтином, вальпроевой кислотой или дексаметазоном in vitro</article-title><trans-title-group xml:lang="en"><trans-title>Study of the anti-inflammatory and immunotropic activity of the secretome from multipotent mesenchymal stromal cells induced by erythropoietin, valproic acid or dexamethasone in vitro</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1765-9042</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Голубинская</surname><given-names>П. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Golubinskaya</surname><given-names>P. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Голубинская Полина Александровна – аспирант, кафедра фармакологии и клинической фармакологии; клеточный инженер</p><p>308015, г. Белгород, ул. Победы, 85309927, Белгородская обл., с. Малобыково, ул. Белая Вежа, 1</p></bio><bio xml:lang="en"><p>85, Pobedy Str., Belgorod, 3080151, Belaya Vezha Str., Malobykovo village, Belgorod region, 309927</p></bio><email xlink:type="simple">polinapigeon@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9279-7584</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пузанов</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Puzanov</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Пузанов Максим Викторович – генеральный директор</p><p>309927, Белгородская обл., с. Малобыково, ул. Белая Вежа, 1</p></bio><bio xml:lang="en"><p>1, Belaya Vezha Str., Malobykovo village, Belgorod region, 309927</p></bio><email xlink:type="simple">maxbff@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3618-5284</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сарычева</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sarycheva</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сарычева Марина Владиславовна – аспирант, кафедра фармакологии и клинической фармакологии</p><p>308015, г. Белгород, ул. Победы, 85</p></bio><bio xml:lang="en"><p>85, Pobedy Str., Belgorod, 308015</p></bio><email xlink:type="simple">dr.sarycheva@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7944-2319</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бурда</surname><given-names>С. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Burda</surname><given-names>S. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бурда Светлана Юрьевна – мл. науч. сотрудник, опытно-производственный участок «Клеточные и вспомогательные репродуктивные технологии»</p><p>308015, г. Белгород, ул. Победы, 85</p></bio><bio xml:lang="en"><p>85, Pobedy Str., Belgorod, 308015</p></bio><email xlink:type="simple">svetlanaburda@gmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6249-2464</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Надеждин</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nadezhdin</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Надеждин Сергей Викторович – канд. биол. наук, доцент, кафедра биологии, Институт фармации, химии и биологии</p><p>308015, г. Белгород, ул. Победы, 85</p></bio><bio xml:lang="en"><p>85, Pobedy Str., Belgorod, 308015</p></bio><email xlink:type="simple">nadezdin@bsu.edu.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5402-0697</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Корокин</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Korokin</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Корокин Михаил Викторович – д-р мед. наук, профессор, кафедра фармакологии и клинической фармакологии</p><p>308015, г. Белгород, ул. Победы, 85</p></bio><bio xml:lang="en"><p>85, Pobedy Str., Belgorod, 308015</p></bio><email xlink:type="simple">mkorokin@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1183-4436</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бурда</surname><given-names>Ю. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Burda</surname><given-names>Yu. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бурда Юрий Евгеньевич – канд. мед. наук, доцент, кафедра фармакологии и клинической фармакологии; директор по науке</p><p>308015, г. Белгород, ул. Победы, 85309927, Белгородская обл., с. Малобыково, ул. Белая Вежа, 1</p></bio><bio xml:lang="en"><p>85, Pobedy Str., Belgorod, 3080151, Belaya Vezha Str., Malobykovo village, Belgorod region, 309927</p></bio><email xlink:type="simple">burda@bsu.edu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Белгородский государственный национальный исследовательский университет (НИУ «БелГУ»); ООО «Центр клеточных технологий Бирюч» (ООО «ЦКТ Бирюч»)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Belgorod State National Research University (NRU BelSU); Biruch Center of Cell Technologies LLC</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ООО «Центр клеточных технологий Бирюч» (ООО «ЦКТ Бирюч»)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Biruch Center of Cell Technologies LLC</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Белгородский государственный национальный исследовательский университет (НИУ «БелГУ»)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Belgorod State National Research University (NRU BelSU)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>14</day><month>04</month><year>2022</year></pub-date><volume>21</volume><issue>1</issue><fpage>28</fpage><lpage>34</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Голубинская П.А., Пузанов М.В., Сарычева М.В., Бурда С.Ю., Надеждин С.В., Корокин М.В., Бурда Ю.Е., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Голубинская П.А., Пузанов М.В., Сарычева М.В., Бурда С.Ю., Надеждин С.В., Корокин М.В., Бурда Ю.Е.</copyright-holder><copyright-holder xml:lang="en">Golubinskaya P.A., Puzanov M.V., Sarycheva M.V., Burda S.Y., Nadezhdin S.V., Korokin M.V., Burda Y.E.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://bulletin.ssmu.ru/jour/article/view/4691">https://bulletin.ssmu.ru/jour/article/view/4691</self-uri><abstract><sec><title>Цель</title><p>Цель. Исследовать влияние обработки вальпроевой кислотой, эритропоэтином и дексаметазоном на противовоспалительную и иммуносупрессивную активность секретома мультипотентных мезенхимальных стромальных клеток (ММСК) жировой ткани в эксперименте in vitro.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. ММСК выделяли из жира шести здоровых доноров. Клетки растили в культуре до четвертого пассажа, затем обрабатывали вальпроевой кислотой, эритропоэтином или дексаметазоном в течение 3 ч, отмывали от препаратов и инкубировали в бессывороточной среде в течение 48 ч. Часть клеток не обрабатывали препаратами. Супернатанты от культур клеток сконцентрировали ультрафильтрацией, стандартизировали по содержанию белка с помощью нанофотометра, стерилизовали и добавляли к мононуклеарам из периферической крови восьми здоровых доноров. Мононуклеары выделяли в градиенте плотности фиколла по стандартному протоколу. Концентрации цитокинов фактора некроза опухоли альфа (TNFα), интерлейкина (IL) 2, IL-4, IL-6, IL-10, интерферона гамма (IFNγ) в суточных культурах и IL-9, IL-10, IL-17A, IL-21 в 48-часовых культурах определяли с помощью мультиплексного анализа.</p></sec><sec><title>Результаты</title><p>Результаты. Продукция IL-2, IL-6, TNFα, IL-10 снижается под действием секретома от обработанных вальпроевой кислотой ММСК. Продукция IL-2, IL-6, TNFα уменьшается при инкубации мононуклеаров с секретомом клеток, обработанных эритпропоэтином. Секретом обработанных дексаметазоном ММСК подавляет продукцию IFNγ, IL-1β, IL-1ra, IL-2, IL-6, IL-9, IL-10, IL-17A. Статистически значимых различий по изменению продукции IL-4, IL-5, IL-9, IL-21 не выявлено.</p></sec><sec><title>Заключение</title><p>Заключение. Среди изученных индукторов дексаметазон показал себя более активным в усилении противовоспалительной и иммуносупрессивной активности ММСК, выраженной через влияние их супернатантов на мононуклеары периферической крови.</p></sec></abstract><trans-abstract xml:lang="en"><p>The aim of this study was to evaluate the effect of treatment with valproic acid, erythropoietin, and dexamethasone on the anti-inflammatory and immunosuppressive activity of the secretome of adipose-derived multipotent mesenchymal stromal cells (MMSCs) in an in vitro experiment.</p><sec><title>Materials and methods</title><p>Materials and methods. MMSCs were isolated from the fat of 6 healthy donors. The cells were grown in the culture up to passage 4. Then they were treated with valproic acid, erythropoietin or dexamethasone for 3 hours, washed from preparations, and incubated in a serum-free medium for 48 hours. Some of the cells were not treated with preparations. Supernatants from the cell cultures were concentrated by ultrafiltration, and protein standardization was performed using a nanophotometer. Then the supernatants were sterilized and added to mononuclear cells from peripheral blood of 8 healthy donors. The mononuclear cells were isolated by Ficoll density gradient centrifugation according to the standard protocol. Concentrations of TNFα, IL-2, IL-4, IL-6, IL-10, and IFNγ cytokines in 24-hour cultures and IL-9, IL-10, IL-17A, and IL-21 cytokines in 48-hour cultures were determined using multiplex analysis.</p></sec><sec><title>Results</title><p>Results. The production of IL-2, IL-6, TNFα, and IL-10 was reduced by the secretome of MMSCs treated with valproic acid. The production of IL-2, IL-6, and TNFα decreased during incubation of the mononuclear cells with the secretome of MMSCs treated with erythropoietin. The secretome of dexamethasone-treated MMSCs suppressed the production of IFNγ, IL-1β, IL-1ra, IL-2, IL-6, IL-9, IL-10, and IL-17A. No statistically significant differences were revealed in the production of IL-4, IL-5, IL-9, and IL-21.</p></sec><sec><title>Conclusion</title><p>Conclusion. Among the studied inducers, dexamethasone enhanced the anti-inflammatory and immunosuppressive activity of MMSCs the most, which was manifested through the effect of their supernatants on peripheral blood mononuclear cells.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>мультипотентные мезенхимальные стромальные клетки</kwd><kwd>вальпроевая кислота</kwd><kwd>эритропоэтин</kwd><kwd>дексаметазон</kwd><kwd>цитокины</kwd><kwd>воспаление</kwd></kwd-group><kwd-group xml:lang="en"><kwd>multipotent mesenchymal stromal cells</kwd><kwd>valproic acid</kwd><kwd>erythropoietin</kwd><kwd>dexamethasone</kwd><kwd>cytokines</kwd><kwd>inflammation</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Авторы заявляют о финансировании со стороны ООО «Инновационный центр «Бирюч – новые технологии», ООО «Центр клеточных технологий Бирюч» и программы «У.М.Н.И.К.».</funding-statement><funding-statement xml:lang="en">The authors declare funding from the Innovation Center “Biruch – New Technologies” LLC, Biruch Cell Technology Center LLC and the UMNIK program.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Golubinskaya P.A., Sarycheva M.V., Burda S.Y., Puzanov M.V., Nadezhdina N.A., Kulikovskiy V.F. et al. Pharmacological modulation of cell functional activity with valproic acid and erythropoietin. Research Results in Pharmacology. 2019;5(2):89–99. DOI: 10.3897/rrpharmacology.5.34710.</mixed-citation><mixed-citation xml:lang="en">Golubinskaya P.A., Sarycheva M.V., Burda S.Y., Puzanov M.V., Nadezhdina N.A., Kulikovskiy V.F. et al. Pharmacological modulation of cell functional activity with valproic acid and erythropoietin. Research Results in Pharmacology. 2019;5(2):89–99. DOI: 10.3897/rrpharmacology.5.34710.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Lu H., Wu X., Wang Z., Li L., Chen W., Yang M. et al. Erythropoietin-activated mesenchymal stem cells promote healing ulcers by improving microenvironment. Journal of Surgical Research. 2016;205(2):464–473. DOI: 10.1016/j.jss.2016.06.086.</mixed-citation><mixed-citation xml:lang="en">Lu H., Wu X., Wang Z., Li L., Chen W., Yang M. et al. Erythropoietin-activated mesenchymal stem cells promote healing ulcers by improving microenvironment. Journal of Surgical Research. 2016;205(2):464–473. DOI: 10.1016/j.jss.2016.06.086.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Leu S.J., Yang Y.Y., Liu H.C., Cheng C.Y., Wu Y.C., Huang M.C. et al. Valproic acid and lithium meditate antiinflammatory effects by differentially modulating dendritic cell differentiation and function. Journal of Cellular Physiology. 2017;232(5):1176–1186. DOI: 10.1002/jcp.25604.</mixed-citation><mixed-citation xml:lang="en">Leu S.J., Yang Y.Y., Liu H.C., Cheng C.Y., Wu Y.C., Huang M.C. et al. Valproic acid and lithium meditate antiinflammatory effects by differentially modulating dendritic cell differentiation and function. Journal of Cellular Physiology. 2017;232(5):1176–1186. DOI: 10.1002/jcp.25604.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">De Almeida A.R., Dantas A.T., Pereira M.C., Cordeiro M.F., Gonçalves R.S.G., de Melo Rêgo M.J.B. et al. Dexamethasone inhibits cytokine production in PBMC from systemic sclerosis patients. Inflammopharmacology. 2019;27(4):723–730. DOI: 10.1007/s10787-019-00600-w.</mixed-citation><mixed-citation xml:lang="en">De Almeida A.R., Dantas A.T., Pereira M.C., Cordeiro M.F., Gonçalves R.S.G., de Melo Rêgo M.J.B. et al. Dexamethasone inhibits cytokine production in PBMC from systemic sclerosis patients. Inflammopharmacology. 2019;27(4):723–730. DOI: 10.1007/s10787-019-00600-w.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Baliwag J., Barnes D.H., Johnston A. Cytokines in psoriasis. Cytokine. 2015;73(2):342–350. DOI: 10.1016/j.cyto.2014.12.014.</mixed-citation><mixed-citation xml:lang="en">Baliwag J., Barnes D.H., Johnston A. Cytokines in psoriasis. Cytokine. 2015;73(2):342–350. DOI: 10.1016/j.cyto.2014.12.014.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Cain D.W., Cidlowski J.A. Immune regulation by glucocorticoids. Nature Reviews Immunology. 2017;17(4):233–247. DOI: 10.1038/nri.2017.1.</mixed-citation><mixed-citation xml:lang="en">Cain D.W., Cidlowski J.A. Immune regulation by glucocorticoids. Nature Reviews Immunology. 2017;17(4):233–247. DOI: 10.1038/nri.2017.1.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Q., Bai H., Wang M.L., Ma H., Zhang X.L., Wang C.B. et al. Effects of the interleukin-21 expression in patients with immune thrombocytopenia and its regulation by high-dose dexamethasone. Zhongguo shi yan xue ye xue za zhi. 2015;23(2):465–470. DOI: 10.7534/j.issn.1009-2137.2015.02.033.</mixed-citation><mixed-citation xml:lang="en">Zhang Q., Bai H., Wang M.L., Ma H., Zhang X.L., Wang C.B. et al. Effects of the interleukin-21 expression in patients with immune thrombocytopenia and its regulation by high-dose dexamethasone. Zhongguo shi yan xue ye xue za zhi. 2015;23(2):465–470. DOI: 10.7534/j.issn.1009-2137.2015.02.033.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Steinborn B., Żarowski M., Winczewska-Wiktor A., Wójcicka M., Młodzikowska-Albrecht J., Losy J. Concentration of Il-1β, Il-2, Il-6, TNFα in the blood serum in children with generalized epilepsy treated by valproate. Pharmacological Reports. 2014;66(6):972–975. DOI: 10.1016/j.pharep.2014.06.005.</mixed-citation><mixed-citation xml:lang="en">Steinborn B., Żarowski M., Winczewska-Wiktor A., Wójcicka M., Młodzikowska-Albrecht J., Losy J. Concentration of Il-1β, Il-2, Il-6, TNFα in the blood serum in children with generalized epilepsy treated by valproate. Pharmacological Reports. 2014;66(6):972–975. DOI: 10.1016/j.pharep.2014.06.005.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Melashchenko O.V., Meniailo M.E., Malashchenko V.V., Gazatova N.D., Goncharov A.G., Seledtsova G.V. et al. Erythropoietin directly affects human macrophage functionality. Current Pharmaceutical Biotechnology. 2018;19(11):902–909. DOI: 10.2174/1389201019666181031164520.</mixed-citation><mixed-citation xml:lang="en">Melashchenko O.V., Meniailo M.E., Malashchenko V.V., Gazatova N.D., Goncharov A.G., Seledtsova G.V. et al. Erythropoietin directly affects human macrophage functionality. Current Pharmaceutical Biotechnology. 2018;19(11):902–909. DOI: 10.2174/1389201019666181031164520.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Banuelos J., Lu N.Z. A gradient of glucocorticoid sensitivity among helper T cell cytokines. Cytokine &amp; Growth Factor Review. 2016; (31):27–35. DOI: 10.1016/j.cytogfr.2016.05.002.</mixed-citation><mixed-citation xml:lang="en">Banuelos J., Lu N.Z. A gradient of glucocorticoid sensitivity among helper T cell cytokines. Cytokine &amp; Growth Factor Review. 2016; (31):27–35. DOI: 10.1016/j.cytogfr.2016.05.002.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Pouya S., Heidari M., Baghaei K., Aghdaei H.A., Moradi A., Namaki S. et al. Study the effects of mesenchymal stem cell conditioned medium injection in mouse model of acute colitis. International Immunopharmacology. 2018;54:86–94. DOI: 10.1016/j.intimp.2017.11.001.</mixed-citation><mixed-citation xml:lang="en">Pouya S., Heidari M., Baghaei K., Aghdaei H.A., Moradi A., Namaki S. et al. Study the effects of mesenchymal stem cell conditioned medium injection in mouse model of acute colitis. International Immunopharmacology. 2018;54:86–94. DOI: 10.1016/j.intimp.2017.11.001.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Rütten S., Schrödl W., Abraham G. Modulation of TNF-α, IL-1Ra and IFN-γ in equine whole blood culture by glucocorticoids. Veterinary Immunology and Immunopathology. 2019;(210):1–5. DOI: 10.1016/j.vetimm.2019.03.002.</mixed-citation><mixed-citation xml:lang="en">Rütten S., Schrödl W., Abraham G. Modulation of TNF-α, IL-1Ra and IFN-γ in equine whole blood culture by glucocorticoids. Veterinary Immunology and Immunopathology. 2019;(210):1–5. DOI: 10.1016/j.vetimm.2019.03.002.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Olivares-Morales M.J., De La Fuente M.K., Dubois-Camacho K., Parada D., Diaz-Jiménez D., Torres-Riquelme A. et al. Glucocorticoids impair phagocytosis and inflammatory response against crohn’s disease-associated adherent-invasive Escherichia coli. Frontiers in Immunology. 2018;(9):1026. DOI: 10.3389/fimmu.2018.01026.</mixed-citation><mixed-citation xml:lang="en">Olivares-Morales M.J., De La Fuente M.K., Dubois-Camacho K., Parada D., Diaz-Jiménez D., Torres-Riquelme A. et al. Glucocorticoids impair phagocytosis and inflammatory response against crohn’s disease-associated adherent-invasive Escherichia coli. Frontiers in Immunology. 2018;(9):1026. DOI: 10.3389/fimmu.2018.01026.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Abd-Elhalem S.S., Haggag N.Z., El-Shinnawy N.A. Bone marrow mesenchymal stem cells suppress IL-9 in adjuvant-induced arthritis. Autoimmunity. 2018;51(1):25–34. DOI: 10.1080/08916934.2018.1428956.</mixed-citation><mixed-citation xml:lang="en">Abd-Elhalem S.S., Haggag N.Z., El-Shinnawy N.A. Bone marrow mesenchymal stem cells suppress IL-9 in adjuvant-induced arthritis. Autoimmunity. 2018;51(1):25–34. DOI: 10.1080/08916934.2018.1428956.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
